Cardinal Health, Inc. CAH
NYSE · Healthcare · Medical - Distribution
$272.81
Close on Fri, 20 Nov 2026 · market value $63.1B
What the price is betting on
Below its recordAt $273, the price assumes revenue shrinks about 7.2% a year for five years, from $258B to about $181B by FY2031. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 7.4% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than CAH? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$487
Base
$547
Bull
$615
Today $273
- Bear $487. Cash flow grows 3% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $547. Cash flow grows 5% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $615. Cash flow grows 7% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2027$244B$266B, on the path
- FY2028$226B$282B, on the path
- FY2029$210B$297B, on the path
- FY2030$195B$307B, on the path
- FY2031$181B$315B, on the path
Each year's revenue at −7.2% growth from $258B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Distribution · listed on NYSE
- Revenue, FY2026
- $254B
- Growth, 3 years a year
- 7.3%
- Cash margin
- 1.8%
- Net debt
- $5.1B
- Shares, 3-year change
- −9.5%
- Dividend yield
- 0.8%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.